Healthcare -
Biotechnology - NASDAQ - US
$ 7.83
0.643 %
$ 1.23 B
Market Cap
-6.07
P/E
OCUL - INTEREST INCOME & EXPENSE
Interest Income & Expense OCUL - Ocular Therapeutix, Inc.
11.3 M
LAST VALUE
30.37%
2 YEAR CAGR
45.49%
5 YEAR CAGR
38.36%
10 YEAR CAGR